Clinical Trials Browser

Penile Neoplasms × lenvatinib × 90 days × Clear all

NCT07384416 2026-05-08

QL1706 Plus Lenvatinib in Previously Treated Penile Cancer

Phase 2 Recruiting

Penile Neoplasms